製品の概要

  • 製品名Flecainide
  • 製品の詳細
    Sodium channel blocker
  • 生理活性の詳細Sodium channel blocker. Class IC antiarrhythmic agent. Inhibits fast Na+ current in cardiac muscle in a use- and concentration-dependent manner. Also inhibits cardiac ryanodine receptors. Orally-active.
  • 精製度> 99%

製品の特性

    Flecainide (ab120504) 使用論文

    This product has been referenced in:
    • Hilliard FA  et al. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol 48:293-301 (2010). Read more (PubMed: 19835880) »
    • Rouet R & Ducouret P Use- and concentration-dependent effects of flecainide in guinea pig right ventricular muscle. J Cardiovasc Pharmacol 24:177-83 (1994). Read more (PubMed: 7526048) »
    • Singh BN  et al. The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions. Ann N Y Acad Sci 432:210-35 (1984). Read more (PubMed: 6395762) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120504.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"